Deoxycytidine

"Deoxycytidine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE.

Descriptor ID	D003841
MeSH Number(s)	D03.383.742.680.245.500 D13.570.230.329 D13.570.685.245.500
Concept/Terms	Deoxycytidine Deoxycytidine Cytosine Deoxyribonucleoside Deoxyribonucleoside, Cytosine Cytosine Deoxyriboside Deoxyriboside, Cytosine

Below are MeSH descriptors whose meaning is more general than "Deoxycytidine".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Pyrimidines [D03.383.742]
Pyrimidine Nucleosides [D03.383.742.680]
Cytidine [D03.383.742.680.245]
Deoxycytidine [D03.383.742.680.245.500]
Nucleic Acids, Nucleotides, and Nucleosides [D13]
Nucleosides [D13.570]
Deoxyribonucleosides [D13.570.230]
Deoxycytidine [D13.570.230.329]
Pyrimidine Nucleosides [D13.570.685]
Cytidine [D13.570.685.245]
Deoxycytidine [D13.570.685.245.500]

Below are MeSH descriptors whose meaning is related to "Deoxycytidine".

Below are MeSH descriptors whose meaning is more specific than "Deoxycytidine".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Deoxycytidine" by people in this website by year, and whether "Deoxycytidine" was a major or minor topic of these publications.

Bar chart showing 25 publications over 16 distinct years, with a maximum of 4 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	0	1
2005	1	1	2
2008	1	0	1
2009	0	1	1
2011	2	2	4
2012	0	2	2
2013	1	0	1
2014	2	0	2
2015	1	0	1
2017	1	1	2
2018	1	0	1
2019	2	1	3
2020	1	0	1
2023	0	1	1
2024	1	0	1
2025	0	1	1

Below are the most recent publications written about "Deoxycytidine" by people in Profiles.

Yi S, Noh K, Kim H, Jung E, Kim S, Lee J, Guk K, Choi J, Lim EK, Kim S, Park H, Lim JH, Jung CR, Kang T, Jung J. Advancing pancreatic cancer therapy by mesothelin-specific nanobody conjugation. Mol Cancer. 2025 Apr 24; 24(1):124.

View in: PubMed
Umar S, Samokhvalov A. Encapsulation of Gemcitabine on Porphyrin Aluminum Metal-Organic Framework by Mechano-Chemistry, Delayed Drug Release and Cytotoxicity to Pancreatic Cancer PANC-1 Cells. Molecules. 2024 Jul 04; 29(13).

View in: PubMed
Inkoom A, Ndemazie NB, Smith T, Frimpong E, Bulusu R, Poku R, Zhu X, Han B, Trevino J, Agyare E. Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. BMC Cancer. 2023 May 13; 23(1):435.

View in: PubMed
Hatami E, Nagesh PKB, Jaggi M, Chauhan SC, Yallapu MM. Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer. Eur J Pharmacol. 2020 Dec 05; 888:173486.

View in: PubMed
Sikander M, Malik S, Khan S, Kumari S, Chauhan N, Khan P, Halaweish FT, Chauhan B, Yallapu MM, Jaggi M, Chauhan SC. Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer). Cells. 2019 Dec 31; 9(1).

View in: PubMed
Parvathaneni S, Sharma S. The DNA repair helicase RECQ1 has a checkpoint-dependent role in mediating DNA damage responses induced by gemcitabine. J Biol Chem. 2019 10 18; 294(42):15330-15345.

View in: PubMed
Khan S, Setua S, Kumari S, Dan N, Massey A, Hafeez BB, Yallapu MM, Stiles ZE, Alabkaa A, Yue J, Ganju A, Behrman S, Jaggi M, Chauhan SC. Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. Biomaterials. 2019 07; 208:83-97.

View in: PubMed
Krulikas LJ, McDonald IM, Lee B, Okumu DO, East MP, Gilbert TSK, Herring LE, Golitz BT, Wells CI, Axtman AD, Zuercher WJ, Willson TM, Kireev D, Yeh JJ, Johnson GL, Baines AT, Graves LM. Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth. SLAS Discov. 2018 09; 23(8):850-861.

View in: PubMed
Affram K, Udofot O, Singh M, Krishnan S, Reams R, Rosenberg J, Agyare E. Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging. PLoS One. 2017; 12(9):e0185116.

View in: PubMed
Youngren-Ortiz SR, Hill DB, Hoffmann PR, Morris KR, Barrett EG, Forest MG, Chougule MB. Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer. J Aerosol Med Pulm Drug Deliv. 2017 Oct; 30(5):299-321.

View in: PubMed

People

Explore

Similar Concepts

Top Journals